AI-Based sTIL analysis expands identification of HER2+ BC patients benefiting from pertuzumab
Dr Supriya Kulkarni speaks to ecancer in an online interview for the virtual BGICC 2021 meeting on the topic of breast cancer surveillance.
She explains that breast cancer surveillance is an important topic due to the increasing incidence of breast cancer across the world as well as the increased success of treatment meaning more women are available for further imaging tests.
Dr Kulkarni details the current guidelines for breast surveillance for women depending on what stage they are at and what treatment and care they have received.
AI-Based sTIL analysis expands identification of HER2+ BC patients benefiting from pertuzumab
ctDNA evaluation may play a prognostic role in stage III colon cancer treated with celecoxib
Insights into germline genetic screening of breast cancer patients
ESMO 2024: Optimising the personalisation of prostate cancer treatment
Best practice in HRRm testing in patients with metastatic prostate cancer
SABCS 2023: Latest breast cancer diagnostics guidelines
Genomic testing: Awareness and effective communication between healthcare professionals and patients
Somatic mutation profile of breast cancer in Uganda
Choosing Wisely in radiology Tanzania